Lincoln Pharmaceuticals Limited — Dividend/Bonus, 22-05-2025: Dividend

Lincoln Pharmaceuticals has announced a board meeting to approve the financial results for the quarter and half-year. The company has proposed a final dividend of Rs. 1.80 per share (18% on face value) for FY25, subject to shareholder approval at the AGM. This payout reflects steady returns alongside a strong FY25 net profit of Rs. 82.44 Cr and EPS of Rs. 41.11, rewarding investors while supporting Lincoln’s growth and global expansion plans.